n studies of schizophrenia, one of the more striking findings is
the delay in the initiation of treatment. That delay ranges from 1
to 2 years for patients experiencing psychotic symptoms to several
years if the prodromal phase is taken into account.
Yet duration of
untreated psychosis has been found to be a critical factor in prognosis,
including psychosocial functioning, in patients with schizophrenia.
Identification of individuals in the prodromal phase not only offers an
opportunity to intervene at an earlier symptomatic stage, but might be
associated with a better response to antipsychotics and a better overall treatment outcome as well